SCG(SH:600170)2022-04-29 16:00Financial Performance - The company's operating revenue for Q1 2022 was ¥53,025,330,121.45, a decrease of 16.28% compared to the same period last year[5] - The net profit attributable to shareholders of the listed company was -¥178,771,118.35, representing a decline of 227.18% year-on-year[5] - The company reported a significant increase in prepayments, which rose to RMB 3.87 billion, up 30% from RMB 2.97 billion in the previous year[15] - The company reported a decrease in comprehensive income, totaling -¥165,414,891.62 in Q1 2022 compared to ¥205,356,415.81 in Q1 2021[20] - The net profit for Q1 2022 was a loss of approximately ¥59.68 million, compared to a loss of ¥225.64 million in Q1 2021, showing an improvement of about 73.5%[27] - The total comprehensive income for Q1 2022 was a loss of approximately ¥59.68 million, compared to a loss of ¥225.64 million in Q1 2021, showing a significant improvement[27] Cash Flow - The net cash flow from operating activities was -¥23,924,186,149.44, down 22.32% from the previous year[5] - Cash flow from operating activities in Q1 2022 was -¥23,924,186,149.44, compared to -¥19,558,399,921.55 in Q1 2021, showing a worsening cash flow situation[22] - The net cash flow from investing activities was -1,647,483,397.96 RMB, compared to -872,316,150.18 RMB in the previous year, indicating a significant increase in cash outflow[23] - The net cash flow from investing activities for Q1 2022 was negative at approximately ¥600.91 million, compared to a positive cash flow of ¥253.93 million in Q1 2021[29] Assets and Liabilities - Total assets at the end of the reporting period were ¥329,138,344,227.46, a decrease of 6.96% from the end of the previous year[6] - The company's current assets totaled RMB 248.13 billion, down 10% from RMB 275.61 billion in the previous year[15] - Total liabilities were reported at RMB 277.57 billion, a decrease of 8% from RMB 302.20 billion in the previous year[16] - The company's total liabilities decreased from 63,677,108,914.98 RMB to 56,999,221,851.98 RMB, a reduction of about 10.5%[26] - The company's total asset value was 88,100,797,282.09 RMB, down from 94,904,383,917.78 RMB, indicating a decline of about 7.2%[26] Equity and Investments - The equity attributable to shareholders of the listed company was ¥40,676,002,111.85, down 0.7% from the end of the previous year[6] - The company's long-term equity investments increased to RMB 6.16 billion, a rise of 4% from RMB 5.91 billion in the previous year[15] - The company's long-term investments increased to 33,207,339,938.39 RMB from 32,382,937,431.87 RMB, reflecting a growth of approximately 2.6%[25] Operational Efficiency and Market Conditions - The company is actively assessing the impact of the Omicron variant on its annual operational targets and is committed to business expansion while ensuring effective epidemic control measures[12] - The company is focused on continuous evaluation of its financial status and operational results in light of ongoing market challenges[12] - The company’s management indicated a focus on improving operational efficiency and exploring new market opportunities moving forward[20] Research and Development - Research and development expenses decreased by 38.64% due to the impact of the pandemic on R&D investments[8] - Research and development expenses for Q1 2022 were ¥864,800,071.50, a decrease of 38.7% from ¥1,409,467,361.42 in Q1 2021[18] - The company incurred research and development expenses of approximately ¥11.93 million in Q1 2022, significantly down from ¥23.51 million in Q1 2021, indicating a reduction of about 49.3%[27] Earnings Per Share - The company’s basic and diluted earnings per share were both -¥0.028, reflecting a significant decrease of 2,860% year-on-year[5] - Basic earnings per share for Q1 2022 were -¥0.028, down from ¥0.001 in Q1 2021[21] - The company reported a basic and diluted earnings per share of -¥0.01 for Q1 2022, compared to -¥0.04 in Q1 2021, indicating a reduction in losses per share[28]